Global SPECT Radiopharmaceuticals Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
Page: 93
Published Date: 02 Jan 2024
Category: Pharma & Healthcare
PDF Download
Get FREE Sample
Customize Request
- Description
- Table of Contents
- Table of Figures
- Research Methodology
- Companies Mentioned
- Related Reports
- Product Tags
Description
According to our (Global Info Research) latest study, the global SPECT Radiopharmaceuticals market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
A Single Photon Emission Computed Tomography (SPECT) scan is a type of nuclear imaging test that shows how blood flows to tissues and organs. Nuclear imaging requires small amounts of radioactive materials called radiopharmaceuticals – injected, inhaled or swallowed – to diagnose disease. SPECT radiopharmaceuticals include Tc-99m, Tl-201, Ga-67, I-123, In-111,and other SPECT isotopes.
The Global Info Research report includes an overview of the development of the SPECT Radiopharmaceuticals industry chain, the market status of Oncology (Technetium-99, Thallium-201), Cardiology (Technetium-99, Thallium-201), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of SPECT Radiopharmaceuticals.
Regionally, the report analyzes the SPECT Radiopharmaceuticals markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global SPECT Radiopharmaceuticals market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the SPECT Radiopharmaceuticals market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the SPECT Radiopharmaceuticals industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Technetium-99, Thallium-201).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the SPECT Radiopharmaceuticals market.
Regional Analysis: The report involves examining the SPECT Radiopharmaceuticals market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the SPECT Radiopharmaceuticals market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to SPECT Radiopharmaceuticals:
Company Analysis: Report covers individual SPECT Radiopharmaceuticals manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards SPECT Radiopharmaceuticals This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Oncology, Cardiology).
Technology Analysis: Report covers specific technologies relevant to SPECT Radiopharmaceuticals. It assesses the current state, advancements, and potential future developments in SPECT Radiopharmaceuticals areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the SPECT Radiopharmaceuticals market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
SPECT Radiopharmaceuticals market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Technetium-99
Thallium-201
Gallium-67
Iodine-123
Indium-111
Other
Market segment by Application
Oncology
Cardiology
Thyroid
Major players covered
GE Healthcare
Cardinal Health
Lantheus Medical Imaging
Bracco Imaging
Eczacibasi-Monrol Nuclear Products
IBA Molecular Imaging
Jubilant Life Sciences
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe SPECT Radiopharmaceuticals product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of SPECT Radiopharmaceuticals, with price, sales, revenue and global market share of SPECT Radiopharmaceuticals from 2019 to 2024.
Chapter 3, the SPECT Radiopharmaceuticals competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the SPECT Radiopharmaceuticals breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and SPECT Radiopharmaceuticals market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of SPECT Radiopharmaceuticals.
Chapter 14 and 15, to describe SPECT Radiopharmaceuticals sales channel, distributors, customers, research findings and conclusion.
Table of Contents
1 Market Overview
1.1 Product Overview and Scope of SPECT Radiopharmaceuticals
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global SPECT Radiopharmaceuticals Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Technetium-99
1.3.3 Thallium-201
1.3.4 Gallium-67
1.3.5 Iodine-123
1.3.6 Indium-111
1.3.7 Other
1.4 Market Analysis by Application
1.4.1 Overview: Global SPECT Radiopharmaceuticals Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Oncology
1.4.3 Cardiology
1.4.4 Thyroid
1.5 Global SPECT Radiopharmaceuticals Market Size & Forecast
1.5.1 Global SPECT Radiopharmaceuticals Consumption Value (2019 & 2023 & 2030)
1.5.2 Global SPECT Radiopharmaceuticals Sales Quantity (2019-2030)
1.5.3 Global SPECT Radiopharmaceuticals Average Price (2019-2030)
2 Manufacturers Profiles
2.1 GE Healthcare
2.1.1 GE Healthcare Details
2.1.2 GE Healthcare Major Business
2.1.3 GE Healthcare SPECT Radiopharmaceuticals Product and Services
2.1.4 GE Healthcare SPECT Radiopharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 GE Healthcare Recent Developments/Updates
2.2 Cardinal Health
2.2.1 Cardinal Health Details
2.2.2 Cardinal Health Major Business
2.2.3 Cardinal Health SPECT Radiopharmaceuticals Product and Services
2.2.4 Cardinal Health SPECT Radiopharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Cardinal Health Recent Developments/Updates
2.3 Lantheus Medical Imaging
2.3.1 Lantheus Medical Imaging Details
2.3.2 Lantheus Medical Imaging Major Business
2.3.3 Lantheus Medical Imaging SPECT Radiopharmaceuticals Product and Services
2.3.4 Lantheus Medical Imaging SPECT Radiopharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Lantheus Medical Imaging Recent Developments/Updates
2.4 Bracco Imaging
2.4.1 Bracco Imaging Details
2.4.2 Bracco Imaging Major Business
2.4.3 Bracco Imaging SPECT Radiopharmaceuticals Product and Services
2.4.4 Bracco Imaging SPECT Radiopharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Bracco Imaging Recent Developments/Updates
2.5 Eczacibasi-Monrol Nuclear Products
2.5.1 Eczacibasi-Monrol Nuclear Products Details
2.5.2 Eczacibasi-Monrol Nuclear Products Major Business
2.5.3 Eczacibasi-Monrol Nuclear Products SPECT Radiopharmaceuticals Product and Services
2.5.4 Eczacibasi-Monrol Nuclear Products SPECT Radiopharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Eczacibasi-Monrol Nuclear Products Recent Developments/Updates
2.6 IBA Molecular Imaging
2.6.1 IBA Molecular Imaging Details
2.6.2 IBA Molecular Imaging Major Business
2.6.3 IBA Molecular Imaging SPECT Radiopharmaceuticals Product and Services
2.6.4 IBA Molecular Imaging SPECT Radiopharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 IBA Molecular Imaging Recent Developments/Updates
2.7 Jubilant Life Sciences
2.7.1 Jubilant Life Sciences Details
2.7.2 Jubilant Life Sciences Major Business
2.7.3 Jubilant Life Sciences SPECT Radiopharmaceuticals Product and Services
2.7.4 Jubilant Life Sciences SPECT Radiopharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Jubilant Life Sciences Recent Developments/Updates
3 Competitive Environment: SPECT Radiopharmaceuticals by Manufacturer
3.1 Global SPECT Radiopharmaceuticals Sales Quantity by Manufacturer (2019-2024)
3.2 Global SPECT Radiopharmaceuticals Revenue by Manufacturer (2019-2024)
3.3 Global SPECT Radiopharmaceuticals Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of SPECT Radiopharmaceuticals by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 SPECT Radiopharmaceuticals Manufacturer Market Share in 2023
3.4.2 Top 6 SPECT Radiopharmaceuticals Manufacturer Market Share in 2023
3.5 SPECT Radiopharmaceuticals Market: Overall Company Footprint Analysis
3.5.1 SPECT Radiopharmaceuticals Market: Region Footprint
3.5.2 SPECT Radiopharmaceuticals Market: Company Product Type Footprint
3.5.3 SPECT Radiopharmaceuticals Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global SPECT Radiopharmaceuticals Market Size by Region
4.1.1 Global SPECT Radiopharmaceuticals Sales Quantity by Region (2019-2030)
4.1.2 Global SPECT Radiopharmaceuticals Consumption Value by Region (2019-2030)
4.1.3 Global SPECT Radiopharmaceuticals Average Price by Region (2019-2030)
4.2 North America SPECT Radiopharmaceuticals Consumption Value (2019-2030)
4.3 Europe SPECT Radiopharmaceuticals Consumption Value (2019-2030)
4.4 Asia-Pacific SPECT Radiopharmaceuticals Consumption Value (2019-2030)
4.5 South America SPECT Radiopharmaceuticals Consumption Value (2019-2030)
4.6 Middle East and Africa SPECT Radiopharmaceuticals Consumption Value (2019-2030)
5 Market Segment by Type
5.1 Global SPECT Radiopharmaceuticals Sales Quantity by Type (2019-2030)
5.2 Global SPECT Radiopharmaceuticals Consumption Value by Type (2019-2030)
5.3 Global SPECT Radiopharmaceuticals Average Price by Type (2019-2030)
6 Market Segment by Application
6.1 Global SPECT Radiopharmaceuticals Sales Quantity by Application (2019-2030)
6.2 Global SPECT Radiopharmaceuticals Consumption Value by Application (2019-2030)
6.3 Global SPECT Radiopharmaceuticals Average Price by Application (2019-2030)
7 North America
7.1 North America SPECT Radiopharmaceuticals Sales Quantity by Type (2019-2030)
7.2 North America SPECT Radiopharmaceuticals Sales Quantity by Application (2019-2030)
7.3 North America SPECT Radiopharmaceuticals Market Size by Country
7.3.1 North America SPECT Radiopharmaceuticals Sales Quantity by Country (2019-2030)
7.3.2 North America SPECT Radiopharmaceuticals Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 Europe
8.1 Europe SPECT Radiopharmaceuticals Sales Quantity by Type (2019-2030)
8.2 Europe SPECT Radiopharmaceuticals Sales Quantity by Application (2019-2030)
8.3 Europe SPECT Radiopharmaceuticals Market Size by Country
8.3.1 Europe SPECT Radiopharmaceuticals Sales Quantity by Country (2019-2030)
8.3.2 Europe SPECT Radiopharmaceuticals Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 Asia-Pacific
9.1 Asia-Pacific SPECT Radiopharmaceuticals Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific SPECT Radiopharmaceuticals Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific SPECT Radiopharmaceuticals Market Size by Region
9.3.1 Asia-Pacific SPECT Radiopharmaceuticals Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific SPECT Radiopharmaceuticals Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 South America
10.1 South America SPECT Radiopharmaceuticals Sales Quantity by Type (2019-2030)
10.2 South America SPECT Radiopharmaceuticals Sales Quantity by Application (2019-2030)
10.3 South America SPECT Radiopharmaceuticals Market Size by Country
10.3.1 South America SPECT Radiopharmaceuticals Sales Quantity by Country (2019-2030)
10.3.2 South America SPECT Radiopharmaceuticals Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 Middle East & Africa
11.1 Middle East & Africa SPECT Radiopharmaceuticals Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa SPECT Radiopharmaceuticals Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa SPECT Radiopharmaceuticals Market Size by Country
11.3.1 Middle East & Africa SPECT Radiopharmaceuticals Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa SPECT Radiopharmaceuticals Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 Market Dynamics
12.1 SPECT Radiopharmaceuticals Market Drivers
12.2 SPECT Radiopharmaceuticals Market Restraints
12.3 SPECT Radiopharmaceuticals Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
13.1 Raw Material of SPECT Radiopharmaceuticals and Key Manufacturers
13.2 Manufacturing Costs Percentage of SPECT Radiopharmaceuticals
13.3 SPECT Radiopharmaceuticals Production Process
13.4 SPECT Radiopharmaceuticals Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 SPECT Radiopharmaceuticals Typical Distributors
14.3 SPECT Radiopharmaceuticals Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Table of Figures
List of Tables
Table 1. Global SPECT Radiopharmaceuticals Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global SPECT Radiopharmaceuticals Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. GE Healthcare Basic Information, Manufacturing Base and Competitors
Table 4. GE Healthcare Major Business
Table 5. GE Healthcare SPECT Radiopharmaceuticals Product and Services
Table 6. GE Healthcare SPECT Radiopharmaceuticals Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. GE Healthcare Recent Developments/Updates
Table 8. Cardinal Health Basic Information, Manufacturing Base and Competitors
Table 9. Cardinal Health Major Business
Table 10. Cardinal Health SPECT Radiopharmaceuticals Product and Services
Table 11. Cardinal Health SPECT Radiopharmaceuticals Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Cardinal Health Recent Developments/Updates
Table 13. Lantheus Medical Imaging Basic Information, Manufacturing Base and Competitors
Table 14. Lantheus Medical Imaging Major Business
Table 15. Lantheus Medical Imaging SPECT Radiopharmaceuticals Product and Services
Table 16. Lantheus Medical Imaging SPECT Radiopharmaceuticals Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Lantheus Medical Imaging Recent Developments/Updates
Table 18. Bracco Imaging Basic Information, Manufacturing Base and Competitors
Table 19. Bracco Imaging Major Business
Table 20. Bracco Imaging SPECT Radiopharmaceuticals Product and Services
Table 21. Bracco Imaging SPECT Radiopharmaceuticals Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Bracco Imaging Recent Developments/Updates
Table 23. Eczacibasi-Monrol Nuclear Products Basic Information, Manufacturing Base and Competitors
Table 24. Eczacibasi-Monrol Nuclear Products Major Business
Table 25. Eczacibasi-Monrol Nuclear Products SPECT Radiopharmaceuticals Product and Services
Table 26. Eczacibasi-Monrol Nuclear Products SPECT Radiopharmaceuticals Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Eczacibasi-Monrol Nuclear Products Recent Developments/Updates
Table 28. IBA Molecular Imaging Basic Information, Manufacturing Base and Competitors
Table 29. IBA Molecular Imaging Major Business
Table 30. IBA Molecular Imaging SPECT Radiopharmaceuticals Product and Services
Table 31. IBA Molecular Imaging SPECT Radiopharmaceuticals Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. IBA Molecular Imaging Recent Developments/Updates
Table 33. Jubilant Life Sciences Basic Information, Manufacturing Base and Competitors
Table 34. Jubilant Life Sciences Major Business
Table 35. Jubilant Life Sciences SPECT Radiopharmaceuticals Product and Services
Table 36. Jubilant Life Sciences SPECT Radiopharmaceuticals Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. Jubilant Life Sciences Recent Developments/Updates
Table 38. Global SPECT Radiopharmaceuticals Sales Quantity by Manufacturer (2019-2024) & (K Units)
Table 39. Global SPECT Radiopharmaceuticals Revenue by Manufacturer (2019-2024) & (USD Million)
Table 40. Global SPECT Radiopharmaceuticals Average Price by Manufacturer (2019-2024) & (USD/Unit)
Table 41. Market Position of Manufacturers in SPECT Radiopharmaceuticals, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 42. Head Office and SPECT Radiopharmaceuticals Production Site of Key Manufacturer
Table 43. SPECT Radiopharmaceuticals Market: Company Product Type Footprint
Table 44. SPECT Radiopharmaceuticals Market: Company Product Application Footprint
Table 45. SPECT Radiopharmaceuticals New Market Entrants and Barriers to Market Entry
Table 46. SPECT Radiopharmaceuticals Mergers, Acquisition, Agreements, and Collaborations
Table 47. Global SPECT Radiopharmaceuticals Sales Quantity by Region (2019-2024) & (K Units)
Table 48. Global SPECT Radiopharmaceuticals Sales Quantity by Region (2025-2030) & (K Units)
Table 49. Global SPECT Radiopharmaceuticals Consumption Value by Region (2019-2024) & (USD Million)
Table 50. Global SPECT Radiopharmaceuticals Consumption Value by Region (2025-2030) & (USD Million)
Table 51. Global SPECT Radiopharmaceuticals Average Price by Region (2019-2024) & (USD/Unit)
Table 52. Global SPECT Radiopharmaceuticals Average Price by Region (2025-2030) & (USD/Unit)
Table 53. Global SPECT Radiopharmaceuticals Sales Quantity by Type (2019-2024) & (K Units)
Table 54. Global SPECT Radiopharmaceuticals Sales Quantity by Type (2025-2030) & (K Units)
Table 55. Global SPECT Radiopharmaceuticals Consumption Value by Type (2019-2024) & (USD Million)
Table 56. Global SPECT Radiopharmaceuticals Consumption Value by Type (2025-2030) & (USD Million)
Table 57. Global SPECT Radiopharmaceuticals Average Price by Type (2019-2024) & (USD/Unit)
Table 58. Global SPECT Radiopharmaceuticals Average Price by Type (2025-2030) & (USD/Unit)
Table 59. Global SPECT Radiopharmaceuticals Sales Quantity by Application (2019-2024) & (K Units)
Table 60. Global SPECT Radiopharmaceuticals Sales Quantity by Application (2025-2030) & (K Units)
Table 61. Global SPECT Radiopharmaceuticals Consumption Value by Application (2019-2024) & (USD Million)
Table 62. Global SPECT Radiopharmaceuticals Consumption Value by Application (2025-2030) & (USD Million)
Table 63. Global SPECT Radiopharmaceuticals Average Price by Application (2019-2024) & (USD/Unit)
Table 64. Global SPECT Radiopharmaceuticals Average Price by Application (2025-2030) & (USD/Unit)
Table 65. North America SPECT Radiopharmaceuticals Sales Quantity by Type (2019-2024) & (K Units)
Table 66. North America SPECT Radiopharmaceuticals Sales Quantity by Type (2025-2030) & (K Units)
Table 67. North America SPECT Radiopharmaceuticals Sales Quantity by Application (2019-2024) & (K Units)
Table 68. North America SPECT Radiopharmaceuticals Sales Quantity by Application (2025-2030) & (K Units)
Table 69. North America SPECT Radiopharmaceuticals Sales Quantity by Country (2019-2024) & (K Units)
Table 70. North America SPECT Radiopharmaceuticals Sales Quantity by Country (2025-2030) & (K Units)
Table 71. North America SPECT Radiopharmaceuticals Consumption Value by Country (2019-2024) & (USD Million)
Table 72. North America SPECT Radiopharmaceuticals Consumption Value by Country (2025-2030) & (USD Million)
Table 73. Europe SPECT Radiopharmaceuticals Sales Quantity by Type (2019-2024) & (K Units)
Table 74. Europe SPECT Radiopharmaceuticals Sales Quantity by Type (2025-2030) & (K Units)
Table 75. Europe SPECT Radiopharmaceuticals Sales Quantity by Application (2019-2024) & (K Units)
Table 76. Europe SPECT Radiopharmaceuticals Sales Quantity by Application (2025-2030) & (K Units)
Table 77. Europe SPECT Radiopharmaceuticals Sales Quantity by Country (2019-2024) & (K Units)
Table 78. Europe SPECT Radiopharmaceuticals Sales Quantity by Country (2025-2030) & (K Units)
Table 79. Europe SPECT Radiopharmaceuticals Consumption Value by Country (2019-2024) & (USD Million)
Table 80. Europe SPECT Radiopharmaceuticals Consumption Value by Country (2025-2030) & (USD Million)
Table 81. Asia-Pacific SPECT Radiopharmaceuticals Sales Quantity by Type (2019-2024) & (K Units)
Table 82. Asia-Pacific SPECT Radiopharmaceuticals Sales Quantity by Type (2025-2030) & (K Units)
Table 83. Asia-Pacific SPECT Radiopharmaceuticals Sales Quantity by Application (2019-2024) & (K Units)
Table 84. Asia-Pacific SPECT Radiopharmaceuticals Sales Quantity by Application (2025-2030) & (K Units)
Table 85. Asia-Pacific SPECT Radiopharmaceuticals Sales Quantity by Region (2019-2024) & (K Units)
Table 86. Asia-Pacific SPECT Radiopharmaceuticals Sales Quantity by Region (2025-2030) & (K Units)
Table 87. Asia-Pacific SPECT Radiopharmaceuticals Consumption Value by Region (2019-2024) & (USD Million)
Table 88. Asia-Pacific SPECT Radiopharmaceuticals Consumption Value by Region (2025-2030) & (USD Million)
Table 89. South America SPECT Radiopharmaceuticals Sales Quantity by Type (2019-2024) & (K Units)
Table 90. South America SPECT Radiopharmaceuticals Sales Quantity by Type (2025-2030) & (K Units)
Table 91. South America SPECT Radiopharmaceuticals Sales Quantity by Application (2019-2024) & (K Units)
Table 92. South America SPECT Radiopharmaceuticals Sales Quantity by Application (2025-2030) & (K Units)
Table 93. South America SPECT Radiopharmaceuticals Sales Quantity by Country (2019-2024) & (K Units)
Table 94. South America SPECT Radiopharmaceuticals Sales Quantity by Country (2025-2030) & (K Units)
Table 95. South America SPECT Radiopharmaceuticals Consumption Value by Country (2019-2024) & (USD Million)
Table 96. South America SPECT Radiopharmaceuticals Consumption Value by Country (2025-2030) & (USD Million)
Table 97. Middle East & Africa SPECT Radiopharmaceuticals Sales Quantity by Type (2019-2024) & (K Units)
Table 98. Middle East & Africa SPECT Radiopharmaceuticals Sales Quantity by Type (2025-2030) & (K Units)
Table 99. Middle East & Africa SPECT Radiopharmaceuticals Sales Quantity by Application (2019-2024) & (K Units)
Table 100. Middle East & Africa SPECT Radiopharmaceuticals Sales Quantity by Application (2025-2030) & (K Units)
Table 101. Middle East & Africa SPECT Radiopharmaceuticals Sales Quantity by Region (2019-2024) & (K Units)
Table 102. Middle East & Africa SPECT Radiopharmaceuticals Sales Quantity by Region (2025-2030) & (K Units)
Table 103. Middle East & Africa SPECT Radiopharmaceuticals Consumption Value by Region (2019-2024) & (USD Million)
Table 104. Middle East & Africa SPECT Radiopharmaceuticals Consumption Value by Region (2025-2030) & (USD Million)
Table 105. SPECT Radiopharmaceuticals Raw Material
Table 106. Key Manufacturers of SPECT Radiopharmaceuticals Raw Materials
Table 107. SPECT Radiopharmaceuticals Typical Distributors
Table 108. SPECT Radiopharmaceuticals Typical Customers
List of Figures
Figure 1. SPECT Radiopharmaceuticals Picture
Figure 2. Global SPECT Radiopharmaceuticals Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global SPECT Radiopharmaceuticals Consumption Value Market Share by Type in 2023
Figure 4. Technetium-99 Examples
Figure 5. Thallium-201 Examples
Figure 6. Gallium-67 Examples
Figure 7. Iodine-123 Examples
Figure 8. Indium-111 Examples
Figure 9. Other Examples
Figure 10. Global SPECT Radiopharmaceuticals Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 11. Global SPECT Radiopharmaceuticals Consumption Value Market Share by Application in 2023
Figure 12. Oncology Examples
Figure 13. Cardiology Examples
Figure 14. Thyroid Examples
Figure 15. Global SPECT Radiopharmaceuticals Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 16. Global SPECT Radiopharmaceuticals Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 17. Global SPECT Radiopharmaceuticals Sales Quantity (2019-2030) & (K Units)
Figure 18. Global SPECT Radiopharmaceuticals Average Price (2019-2030) & (USD/Unit)
Figure 19. Global SPECT Radiopharmaceuticals Sales Quantity Market Share by Manufacturer in 2023
Figure 20. Global SPECT Radiopharmaceuticals Consumption Value Market Share by Manufacturer in 2023
Figure 21. Producer Shipments of SPECT Radiopharmaceuticals by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 22. Top 3 SPECT Radiopharmaceuticals Manufacturer (Consumption Value) Market Share in 2023
Figure 23. Top 6 SPECT Radiopharmaceuticals Manufacturer (Consumption Value) Market Share in 2023
Figure 24. Global SPECT Radiopharmaceuticals Sales Quantity Market Share by Region (2019-2030)
Figure 25. Global SPECT Radiopharmaceuticals Consumption Value Market Share by Region (2019-2030)
Figure 26. North America SPECT Radiopharmaceuticals Consumption Value (2019-2030) & (USD Million)
Figure 27. Europe SPECT Radiopharmaceuticals Consumption Value (2019-2030) & (USD Million)
Figure 28. Asia-Pacific SPECT Radiopharmaceuticals Consumption Value (2019-2030) & (USD Million)
Figure 29. South America SPECT Radiopharmaceuticals Consumption Value (2019-2030) & (USD Million)
Figure 30. Middle East & Africa SPECT Radiopharmaceuticals Consumption Value (2019-2030) & (USD Million)
Figure 31. Global SPECT Radiopharmaceuticals Sales Quantity Market Share by Type (2019-2030)
Figure 32. Global SPECT Radiopharmaceuticals Consumption Value Market Share by Type (2019-2030)
Figure 33. Global SPECT Radiopharmaceuticals Average Price by Type (2019-2030) & (USD/Unit)
Figure 34. Global SPECT Radiopharmaceuticals Sales Quantity Market Share by Application (2019-2030)
Figure 35. Global SPECT Radiopharmaceuticals Consumption Value Market Share by Application (2019-2030)
Figure 36. Global SPECT Radiopharmaceuticals Average Price by Application (2019-2030) & (USD/Unit)
Figure 37. North America SPECT Radiopharmaceuticals Sales Quantity Market Share by Type (2019-2030)
Figure 38. North America SPECT Radiopharmaceuticals Sales Quantity Market Share by Application (2019-2030)
Figure 39. North America SPECT Radiopharmaceuticals Sales Quantity Market Share by Country (2019-2030)
Figure 40. North America SPECT Radiopharmaceuticals Consumption Value Market Share by Country (2019-2030)
Figure 41. United States SPECT Radiopharmaceuticals Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 42. Canada SPECT Radiopharmaceuticals Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 43. Mexico SPECT Radiopharmaceuticals Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 44. Europe SPECT Radiopharmaceuticals Sales Quantity Market Share by Type (2019-2030)
Figure 45. Europe SPECT Radiopharmaceuticals Sales Quantity Market Share by Application (2019-2030)
Figure 46. Europe SPECT Radiopharmaceuticals Sales Quantity Market Share by Country (2019-2030)
Figure 47. Europe SPECT Radiopharmaceuticals Consumption Value Market Share by Country (2019-2030)
Figure 48. Germany SPECT Radiopharmaceuticals Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 49. France SPECT Radiopharmaceuticals Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 50. United Kingdom SPECT Radiopharmaceuticals Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 51. Russia SPECT Radiopharmaceuticals Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 52. Italy SPECT Radiopharmaceuticals Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 53. Asia-Pacific SPECT Radiopharmaceuticals Sales Quantity Market Share by Type (2019-2030)
Figure 54. Asia-Pacific SPECT Radiopharmaceuticals Sales Quantity Market Share by Application (2019-2030)
Figure 55. Asia-Pacific SPECT Radiopharmaceuticals Sales Quantity Market Share by Region (2019-2030)
Figure 56. Asia-Pacific SPECT Radiopharmaceuticals Consumption Value Market Share by Region (2019-2030)
Figure 57. China SPECT Radiopharmaceuticals Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. Japan SPECT Radiopharmaceuticals Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. Korea SPECT Radiopharmaceuticals Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 60. India SPECT Radiopharmaceuticals Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 61. Southeast Asia SPECT Radiopharmaceuticals Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 62. Australia SPECT Radiopharmaceuticals Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 63. South America SPECT Radiopharmaceuticals Sales Quantity Market Share by Type (2019-2030)
Figure 64. South America SPECT Radiopharmaceuticals Sales Quantity Market Share by Application (2019-2030)
Figure 65. South America SPECT Radiopharmaceuticals Sales Quantity Market Share by Country (2019-2030)
Figure 66. South America SPECT Radiopharmaceuticals Consumption Value Market Share by Country (2019-2030)
Figure 67. Brazil SPECT Radiopharmaceuticals Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 68. Argentina SPECT Radiopharmaceuticals Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 69. Middle East & Africa SPECT Radiopharmaceuticals Sales Quantity Market Share by Type (2019-2030)
Figure 70. Middle East & Africa SPECT Radiopharmaceuticals Sales Quantity Market Share by Application (2019-2030)
Figure 71. Middle East & Africa SPECT Radiopharmaceuticals Sales Quantity Market Share by Region (2019-2030)
Figure 72. Middle East & Africa SPECT Radiopharmaceuticals Consumption Value Market Share by Region (2019-2030)
Figure 73. Turkey SPECT Radiopharmaceuticals Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 74. Egypt SPECT Radiopharmaceuticals Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 75. Saudi Arabia SPECT Radiopharmaceuticals Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 76. South Africa SPECT Radiopharmaceuticals Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 77. SPECT Radiopharmaceuticals Market Drivers
Figure 78. SPECT Radiopharmaceuticals Market Restraints
Figure 79. SPECT Radiopharmaceuticals Market Trends
Figure 80. Porters Five Forces Analysis
Figure 81. Manufacturing Cost Structure Analysis of SPECT Radiopharmaceuticals in 2023
Figure 82. Manufacturing Process Analysis of SPECT Radiopharmaceuticals
Figure 83. SPECT Radiopharmaceuticals Industrial Chain
Figure 84. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 85. Direct Channel Pros & Cons
Figure 86. Indirect Channel Pros & Cons
Figure 87. Methodology
Figure 88. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
GE Healthcare Cardinal Health Lantheus Medical Imaging Bracco Imaging Eczacibasi-Monrol Nuclear Products IBA Molecular Imaging Jubilant Life Sciences
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
-
Insight into the industry market information
-
Analyze market development needs
-
Prospects for future development
-
Develop industry investment strategy
-
- Digging deeper into global industry information and providing market strategies.Contact Us >>